In silico investigation of cytochrome bc1 molecular inhibition mechanism against Trypanosoma cruzi.

Chagas' disease is a neglected tropical disease caused by the kinetoplastid protozoan Trypanosoma cruzi. The only therapies are the nitroheterocyclic chemicals nifurtimox and benznidazole that cause various adverse effects. The need to create safe and effective medications to improve medical ca...

Full description

Bibliographic Details
Published in:PLOS Neglected Tropical Diseases
Main Authors: Stefano Muscat, Gianvito Grasso, Leonardo Scapozza, Andrea Danani
Format: Article in Journal/Newspaper
Language:English
Published: Public Library of Science (PLoS) 2023
Subjects:
Online Access:https://doi.org/10.1371/journal.pntd.0010545
https://doaj.org/article/0abe6a01cc204a61baced8f759d0fab2
id ftdoajarticles:oai:doaj.org/article:0abe6a01cc204a61baced8f759d0fab2
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:0abe6a01cc204a61baced8f759d0fab2 2023-05-15T15:11:02+02:00 In silico investigation of cytochrome bc1 molecular inhibition mechanism against Trypanosoma cruzi. Stefano Muscat Gianvito Grasso Leonardo Scapozza Andrea Danani 2023-01-01T00:00:00Z https://doi.org/10.1371/journal.pntd.0010545 https://doaj.org/article/0abe6a01cc204a61baced8f759d0fab2 EN eng Public Library of Science (PLoS) https://doi.org/10.1371/journal.pntd.0010545 https://doaj.org/toc/1935-2727 https://doaj.org/toc/1935-2735 1935-2727 1935-2735 doi:10.1371/journal.pntd.0010545 https://doaj.org/article/0abe6a01cc204a61baced8f759d0fab2 PLoS Neglected Tropical Diseases, Vol 17, Iss 1, p e0010545 (2023) Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 article 2023 ftdoajarticles https://doi.org/10.1371/journal.pntd.0010545 2023-02-19T01:28:16Z Chagas' disease is a neglected tropical disease caused by the kinetoplastid protozoan Trypanosoma cruzi. The only therapies are the nitroheterocyclic chemicals nifurtimox and benznidazole that cause various adverse effects. The need to create safe and effective medications to improve medical care remains critical. The lack of verified T. cruzi therapeutic targets hinders medication research for Chagas' disease. In this respect, cytochrome bc1 has been identified as a promising therapeutic target candidate for antibacterial medicines of medical and agricultural interest. Cytochrome bc1 belongs to the mitochondrial electron transport chain and transfers electrons from ubiquinol to cytochrome c1 by the action of two catalytic sites named Qi and Qo. The two binding sites are highly selective, and specific inhibitors exist for each site. Recent studies identified the Qi site of the cytochrome bc1 as a promising drug target against T. cruzi. However, a lack of knowledge of the drug mechanism of action unfortunately hinders the development of new therapies. In this context, knowing the cause of binding site selectivity and the mechanism of action of inhibitors and substrates is crucial for drug discovery and optimization processes. In this paper, we provide a detailed computational investigation of the Qi site of T. cruzi cytochrome b to shed light on the molecular mechanism of action of known inhibitors and substrates. Our study emphasizes the action of inhibitors at the Qi site on a highly unstructured portion of cytochrome b that could be related to the biological function of the electron transport chain complex. Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic PLOS Neglected Tropical Diseases 17 1 e0010545
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
topic Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
spellingShingle Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
Stefano Muscat
Gianvito Grasso
Leonardo Scapozza
Andrea Danani
In silico investigation of cytochrome bc1 molecular inhibition mechanism against Trypanosoma cruzi.
topic_facet Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
description Chagas' disease is a neglected tropical disease caused by the kinetoplastid protozoan Trypanosoma cruzi. The only therapies are the nitroheterocyclic chemicals nifurtimox and benznidazole that cause various adverse effects. The need to create safe and effective medications to improve medical care remains critical. The lack of verified T. cruzi therapeutic targets hinders medication research for Chagas' disease. In this respect, cytochrome bc1 has been identified as a promising therapeutic target candidate for antibacterial medicines of medical and agricultural interest. Cytochrome bc1 belongs to the mitochondrial electron transport chain and transfers electrons from ubiquinol to cytochrome c1 by the action of two catalytic sites named Qi and Qo. The two binding sites are highly selective, and specific inhibitors exist for each site. Recent studies identified the Qi site of the cytochrome bc1 as a promising drug target against T. cruzi. However, a lack of knowledge of the drug mechanism of action unfortunately hinders the development of new therapies. In this context, knowing the cause of binding site selectivity and the mechanism of action of inhibitors and substrates is crucial for drug discovery and optimization processes. In this paper, we provide a detailed computational investigation of the Qi site of T. cruzi cytochrome b to shed light on the molecular mechanism of action of known inhibitors and substrates. Our study emphasizes the action of inhibitors at the Qi site on a highly unstructured portion of cytochrome b that could be related to the biological function of the electron transport chain complex.
format Article in Journal/Newspaper
author Stefano Muscat
Gianvito Grasso
Leonardo Scapozza
Andrea Danani
author_facet Stefano Muscat
Gianvito Grasso
Leonardo Scapozza
Andrea Danani
author_sort Stefano Muscat
title In silico investigation of cytochrome bc1 molecular inhibition mechanism against Trypanosoma cruzi.
title_short In silico investigation of cytochrome bc1 molecular inhibition mechanism against Trypanosoma cruzi.
title_full In silico investigation of cytochrome bc1 molecular inhibition mechanism against Trypanosoma cruzi.
title_fullStr In silico investigation of cytochrome bc1 molecular inhibition mechanism against Trypanosoma cruzi.
title_full_unstemmed In silico investigation of cytochrome bc1 molecular inhibition mechanism against Trypanosoma cruzi.
title_sort in silico investigation of cytochrome bc1 molecular inhibition mechanism against trypanosoma cruzi.
publisher Public Library of Science (PLoS)
publishDate 2023
url https://doi.org/10.1371/journal.pntd.0010545
https://doaj.org/article/0abe6a01cc204a61baced8f759d0fab2
geographic Arctic
geographic_facet Arctic
genre Arctic
genre_facet Arctic
op_source PLoS Neglected Tropical Diseases, Vol 17, Iss 1, p e0010545 (2023)
op_relation https://doi.org/10.1371/journal.pntd.0010545
https://doaj.org/toc/1935-2727
https://doaj.org/toc/1935-2735
1935-2727
1935-2735
doi:10.1371/journal.pntd.0010545
https://doaj.org/article/0abe6a01cc204a61baced8f759d0fab2
op_doi https://doi.org/10.1371/journal.pntd.0010545
container_title PLOS Neglected Tropical Diseases
container_volume 17
container_issue 1
container_start_page e0010545
_version_ 1766341952501972992